Connect Biopharma Holdings CNTB
NASDAQ CNTB
$0.83 -0.05 (-5.70%)
As of: Oct 21, 2026 · 2:04 PM EDT

Connect Biopharma Holdings (CNTB) FCF Margin (2024 - 2026)

Updated

Connect Biopharma Holdings' FCF Margin came in at -575.22% for Q2 2026, up 26287.28 percentage points from -26862.50% a year earlier and up 8895.20 percentage points from the prior quarter.

Analysis

Connect Biopharma Holdings (CNTB) FCF Margin (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Connect Biopharma Holdings reported FCF Margin of -2053.27%, down 82.78 percentage points year-over-year; for FY2025, it was -80687.50%, down 80593.92 percentage points from FY2024.

  • Going back by year, FCF Margin was -93.58% in FY2024.
  • The Q2 2026 figure represents the highest quarterly FCF Margin since Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,134.61 Bn 1,103.20 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 616.25 Bn 534.77 Bn 17.26 Bn 28.82%
3 AbbVie 501.45 Bn 474.56 Bn 12.70 Bn 18.33%
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 26.96%
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 38.60%
6 Astrazeneca 261.44 Bn 235.12 Bn 12.86 Bn 6.55%
7 Amgen 235.87 Bn 191.27 Bn 7.24 Bn 34.70%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 44.00%
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn 2.01%
10 Connect Biopharma Holdings 51.90 Mn -124.78 Mn - -575.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -575.22%
Mar 31, 2026 -9,470.41%
Sep 30, 2025 -109,000.00%
Jun 30, 2025 -26,862.50%
Dec 31, 2024 -377.08%
Sep 30, 2024 -1,079.08%
API Access

Connect Biopharma Holdings FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=CNTB&period=max&api_key=YOUR_API_KEY